Bank of Nova Scotia’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-52,400
Closed -$4.15M 854
2019
Q1
$4.15M Hold
52,400
0.02% 474
2018
Q4
$3.82M Hold
52,400
0.02% 456
2018
Q3
$3.55M Buy
+52,400
New +$3.34M 0.02% 503
2018
Q2
Sell
-52,400
Closed -$2.72M 915
2018
Q1
$2.72M Hold
52,400
0.01% 499
2017
Q4
$2.81M Buy
+52,400
New +$2.9M 0.01% 511
2017
Q1
Sell
-26,200
Closed -$1.47M 909
2016
Q4
$1.47M Buy
+26,200
New +$1.53M 0.01% 426

Other funds holding MRK

Bank of Nova Scotia's MRK Position: Q1 2026 in Review

Bank of Nova Scotia reduced its Merck (MRK) stake by 26% in Q1 2026, selling an estimated $57.6M and leaving 1,457,238 shares worth $175M. The position accounts for 0.31% of the portfolio, ranked #55.

Bank of Nova Scotia first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $343M in Q4 2023. 3,788 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Bank of Nova Scotia held 1,457,238 shares of Merck worth $175M as of Q1 2026.
  • Bank of Nova Scotia sold 498,962 Merck shares in Q1 2026, an estimated $57.6M.
  • Merck made up 0.31% of Bank of Nova Scotia's portfolio in Q1 2026, its #55 holding.
  • Bank of Nova Scotia first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Bank of Nova Scotia's Merck position peaked at $343M in Q4 2023.
  • 3,788 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.